Advanced search
1 file | 751.86 KB Add to list

A personalized view on cancer immunotherapy

Laura Wayteck (UGent) , Karine Breckpot, Jo Demeester (UGent) , Stefaan De Smedt (UGent) and Koen Raemdonck (UGent)
(2014) CANCER LETTERS. 352(1). p.113-125
Author
Organization
Keywords
Predictive biomarkers, Tumor heterogeneity, Tumor antigens, Cancer immunotherapy, Personalized medicine, Adoptive T cell therapy, CD8(+) T-CELLS, CHIMERIC-ANTIGEN-RECEPTOR, ACUTE MYELOID-LEUKEMIA, IMMUNOSTIMULATORY MONOCLONAL-ANTIBODIES, TUMOR-INFILTRATING LYMPHOCYTES, EPITHELIAL OVARIAN-CANCER, METASTATIC MELANOMA, MESSENGER-RNA, DENDRITIC CELLS, CANCER/TESTIS ANTIGENS

Downloads

  • apersonalized.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 751.86 KB

Citation

Please use this url to cite or link to this publication:

MLA
Wayteck, Laura, et al. “A Personalized View on Cancer Immunotherapy.” CANCER LETTERS, vol. 352, no. 1, 2014, pp. 113–25, doi:10.1016/j.canlet.2013.09.016.
APA
Wayteck, L., Breckpot, K., Demeester, J., De Smedt, S., & Raemdonck, K. (2014). A personalized view on cancer immunotherapy. CANCER LETTERS, 352(1), 113–125. https://doi.org/10.1016/j.canlet.2013.09.016
Chicago author-date
Wayteck, Laura, Karine Breckpot, Jo Demeester, Stefaan De Smedt, and Koen Raemdonck. 2014. “A Personalized View on Cancer Immunotherapy.” CANCER LETTERS 352 (1): 113–25. https://doi.org/10.1016/j.canlet.2013.09.016.
Chicago author-date (all authors)
Wayteck, Laura, Karine Breckpot, Jo Demeester, Stefaan De Smedt, and Koen Raemdonck. 2014. “A Personalized View on Cancer Immunotherapy.” CANCER LETTERS 352 (1): 113–125. doi:10.1016/j.canlet.2013.09.016.
Vancouver
1.
Wayteck L, Breckpot K, Demeester J, De Smedt S, Raemdonck K. A personalized view on cancer immunotherapy. CANCER LETTERS. 2014;352(1):113–25.
IEEE
[1]
L. Wayteck, K. Breckpot, J. Demeester, S. De Smedt, and K. Raemdonck, “A personalized view on cancer immunotherapy,” CANCER LETTERS, vol. 352, no. 1, pp. 113–125, 2014.
@article{5870003,
  author       = {{Wayteck, Laura and Breckpot, Karine and Demeester, Jo and De Smedt, Stefaan and Raemdonck, Koen}},
  issn         = {{0304-3835}},
  journal      = {{CANCER LETTERS}},
  keywords     = {{Predictive biomarkers,Tumor heterogeneity,Tumor antigens,Cancer immunotherapy,Personalized medicine,Adoptive T cell therapy,CD8(+) T-CELLS,CHIMERIC-ANTIGEN-RECEPTOR,ACUTE MYELOID-LEUKEMIA,IMMUNOSTIMULATORY MONOCLONAL-ANTIBODIES,TUMOR-INFILTRATING LYMPHOCYTES,EPITHELIAL OVARIAN-CANCER,METASTATIC MELANOMA,MESSENGER-RNA,DENDRITIC CELLS,CANCER/TESTIS ANTIGENS}},
  language     = {{eng}},
  number       = {{1}},
  pages        = {{113--125}},
  title        = {{A personalized view on cancer immunotherapy}},
  url          = {{http://doi.org/10.1016/j.canlet.2013.09.016}},
  volume       = {{352}},
  year         = {{2014}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: